MDS (MYELODYSPLASTIC SYNDROME)
Clinical trials for MDS (MYELODYSPLASTIC SYNDROME) explained in plain language.
Never miss a new study
Get alerted when new MDS (MYELODYSPLASTIC SYNDROME) trials appear
Sign up with your email to follow new studies for MDS (MYELODYSPLASTIC SYNDROME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test gentler prep for blood cancer transplants
Disease control Not yet recruitingThis study is testing the safety of adding a drug called venetoclax to a standard, lower-intensity chemotherapy regimen given before a stem cell transplant. The goal is to see if this combination can better control acute myeloid leukemia (AML) or high-risk myelodysplastic syndrom…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
15-Year watch: tracking patients after experimental cancer cell therapy
Disease control Not yet recruitingThis study will monitor patients for 15 years after they received an experimental CAR-T cell therapy for relapsed or hard-to-treat blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The main goal is to understand the long-term safety of the treatm…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Sponsor: ARCE Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Weekly shot vs. daily injection: race to stop bleeding after transplant
Disease control Not yet recruitingThis study is for adults with MDS or aplastic anemia who are getting a donor stem cell transplant. After transplant, patients often struggle to make enough platelets, which are cells that help stop bleeding. The study will compare a new weekly injection (romiplostim) against a st…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New transplant prep could boost survival for blood cancer patients
Disease control Not yet recruitingThis study aims to find out which of two chemotherapy drugs works better to prepare patients for a stem cell transplant for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). It will compare treosulfan and melphalan in 220 adult patients who are at higher risk for si…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC